Clinical Trials
29 trialsA Phase l Study of By101921, an Oral PARP7 Inhibitor, in Patients With Advanced Solid Tumors
Chengdu Baiyu Pharmaceutical Co., Ltd.
Zotatifin
Effector Therapeutics
Study to Evaluate the Drug-drug Interaction of JMKX001899 in Healthy Subjects
Jemincare
Clinical Study on the Treatment of Advanced Recurrent Tumors With Anticancer Mouse Characteristic Human Neutrophils
Wuxi People's Hospital
A Study of BH009 in Head and Neck Squamous Cell Carcinoma and Ovarian Cancer
Zhuhai Beihai Biotech Co., Ltd
Tolerability and Safety of HF1K16 Injection in Patients With Refractory Solid Tumors
HighField Biopharmaceuticals Corporation
A Study of HB0045 Injection in Patients With Advanced Solid Tumors
Shanghai Huaota Biopharmaceutical Co., Ltd.
A Study of Bio-008 in Subjects With Advanced or Metastatic Solid Tumours
Shijiazhuang Yiling Pharmaceutical Co. Ltd
Phase 1 Study of RBN-2397, an Oral PARP7 Inhibitor, in Patients With Solid Tumors
Ribon Therapeutics, Inc.
A Study of HS248 in Patients With Advanced Solid Tumors
Hanhui Pharmaceutical Co., Ltd
Fluoride-labeled Boronophenylalanine PET Imaging in Patients With Solid Tumors
Tongji Hospital
Safety Study of 177Lu-Anti-ED-B mAbs SPECT Imaging in Patients With ED-B Positive Solid Tumors
Affiliated Hospital of Jiangnan University
TGFβR-KO CAR-EGFR T Cells in Previously Treated Advanced EGFR-positive Solid Tumors
Chinese PLA General Hospital
A Phase I Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetic Characteristics, and Preliminary Efficacy of HLX35 in Combination With HLX10 in Patients With Advanced or Metastatic Solid Tumors
Shanghai Henlius Biotech
IMPRESS
Royal Marsden NHS Foundation Trust
A Study of of HOT1030 in Patients With Advanced Solid Tumors
Huabo Biopharm Co., Ltd.
Safety Study of 89Zr-Anti-CLDN18.2 mAbs PET Imaging in Patients With CLDN18.2 Positive Solid Tumors
Wuxi No. 4 People's Hospital
Safety Study of 89Zr-NY001 PET Imaging in Patients
Wuxi No. 4 People's Hospital
89Zr-labeled KN035 PET Imaging in Patients With PD-L1 Positive Solid Tumors
Wuxi No. 4 People's Hospital
POCCP1
Ministry of Health, Malaysia
Evaluate Safety, Tolerability and PK of HLX55 in Patients With Advanced Solid Tumors With Different cMET Status
Henlix, Inc
A Study of HMPL-453 in Patients With Advanced Solid Malignancies
Hutchmed
Advanced Refractory Solid Tumors With TP53 Mutations Register Study
Tianjin Medical University Second Hospital
CPV2-0
Institut Paoli-Calmettes
Personalized Therapy of Molecular Tumor Board Participation With the Guidance of Next Generation Sequencing
Tianjin Medical University Second Hospital
89Zr-KN035 PET Imaging in Patients With Advanced Solid Tumors
The First Affiliated Hospital of Soochow University
Study of PD-1 Gene-knocked Out Mesothelin-directed CAR-T Cells With the Conditioning of PC in Mesothelin Positive Multiple Solid Tumors
Chinese PLA General Hospital
Safety and Tolerability of HTI-1066 in Subjects With Advanced Solid Tumors
Jiangsu HengRui Medicine Co., Ltd.
PD-1 Antibody Expressing CAR T Cells for Mesothelin Positive Advanced Malignancies
Ningbo Cancer Hospital